BUSINESS
—
scroll down

Daying Technology wins the "2018 Haichuang Best New Star" award


On January 17, 2019, the "2018 Haichuang Entrepreneurship Role Model" event was held at the Zhongguancun Entrepreneurship Building in the Zhongguancun Haidian Science and Technology Park. Beijing Daying Technology Co., Ltd. (hereinafter referred to as "Daying Technology") won the "Annual Haichuang Best New Star" award.

 

1

 

Founded in June 2017, Daying Technology is a Sino-foreign joint venture specializing in high-end medical imaging equipment, dedicated to the research and development of medical imaging equipment with independent intellectual property rights. The company is currently developing a "3D digital mammography machine" that can reduce the difficulty of breast cancer screening, help primary hospitals improve the accuracy of examinations, and provide a basis for patients to be detected and treated early.

 

1

 

With the rapid development of China's economy and society, the improvement of residents' living standards, and the upgrading of health management needs, the medical and health industry has huge market potential. In the process of deploying the entire medical and health industry, China Zhongji Investment mainly focuses on the enterprises' independent innovation capabilities, the team's execution capabilities, and the products' accessibility to the general public. Mr. Wu Tao, Chairman and General Manager of Daying Technology, has more than 20 years of experience in the field of 3D digital breast imaging. He participated in the full R&D process of mature, clinically validated products in the United States, and is leading the development of new products, which, after launch, will significantly improve the accuracy of breast cancer screening for women in primary hospitals. China Zhongji Investment participated in Daying Technology's angel round financing in June 2017, jointly seizing market opportunities in the medical and health industry.

 

China Zhongji Investment remains optimistic about projects and enterprises in the medical and health industry with strong independent innovation capabilities.